tiprankstipranks

David S. Ege Insider Profile

11 Followers
David S. Ege, EVP and CTO at Seres Therapeutics, holds 73.86K shares in Seres Therapeutics (Ticker: MCRB).
tipranks
David S. Ege

David S. Ege
Seres Therapeutics (MCRB)
EVP and CTO

Not Ranked
David S. Ege has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$86K
100.00%
A breakdown of David S. Ege's holdings

Insider Roles

Seres Therapeutics
(MCRB)
EVP and CTO
Roles that David S. Ege holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by David S. Ege

David S. Ege's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Seres Therapeutics
Feb 16, 2024
EVP and CTO
Uninformative Sell
5.41K
$85.67K
David S. Ege has not reported any informative transactions for MCRB, therefore, performance cannot be measured.
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Oct 31, 2022
Uninformative Buy
$0.00
-
$0.00
May 01, 2023
Uninformative Buy
$0.00
-
$0.00
Oct 31, 2022
Uninformative Sell
$39.75K
-
$7.93
May 01, 2023
Uninformative Sell
$36.53K
-
$5.19
Oct 31, 2023
Uninformative Sell
$5.49K
-
$0.00
List of latest transactions for each holding click on a transaction to see David S. Ege's performance on stock

David S. Ege insider profile FAQ

What is the percentage of profitable transactions made by David S. Ege?
The percentage of profitable transactions made by David S. Ege is ―.
    What is the average return per transaction made by David S. Ege?
    The average return per transaction made by David S. Ege is ―.
      What stocks does David S. Ege hold?
      David S. Ege holds: MCRB stocks.
        What was David S. Ege’s latest transaction?
        David S. Ege latest transaction was an Uninformative Sell of $5.41K.
          What was David S. Ege's most profitable transaction?
          David S. Ege’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is David S. Ege's role in Seres Therapeutics?
            David S. Ege's role in Seres Therapeutics is EVP and CTO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.